leucine by rat skeletal muscle. Am. J. Physiol. 223 (6) : 1376-1383. 1972 .-In the isolated rat diaphragm, 14C02 production from L-leucine-1 -14C occurred at 86 y0 of the rate of its incorporation into protein. Experiments with L-leucine-U-14C indicate complete oxidation of leucine under these conditions. 14C02 production from leucine-1-14C was inhibited slightly by glucose (15 %) but not by acetate, pyruvate, P-hydroxbutyrate, or palmitate. Amino acids at plasma concentrations inhibited 14C02 production (3O-40 (r,) without affecting protein synthesis. Cycloheximide blocked incorporation into protein but stimulated 14C02 production, whereas cyanide and iodoacetate inhibited both processes. Addition of ouabain or the removal of Na+ from the incubation medium inhibited incorporation into protein but not oxidation. Appreciable oxidation of leucine also occurred in the dark soleus and the pale extensor digitorum longus muscles. The diaphragm catabolized leucine at rates similar to liver slices but severalfold less actively than epidydimal fat pad or kidney and brain slices. Since skeletal muscle accounts for over 400/, of the body mass, muscle is probably the major site of leucine catabolism in the animal. amino acid metabolism; diaphragm; protein synthesis; amino acid transport; energy metabolism; rat tissues THE LIVER is generally believed to be the major site of amino acid degradation in mammals (1). Miller (29, 30) , however, using eviscerated rats showed that nonhepatic tissues have a marked ability to oxidize certain amino acids, including leucine, isoleucine, valine, glutamic acid, aspartic acid, and proline.
The site of this nonhepatic oxidation has not been clearly established, although both the kidney (6, 13) and adipose tissue (13, 14) can catabolize several of these amino acids to CO2. It has widely been assumed that skeletal muscle burns only carbohydrates and fatty acids and that amino acids in this tissue serve only as precursor for protein synthesis. However, transaminases for amino acids (46) , including the branched-chain amino acids (18), have been found in high concentration in skeletal muscle. Since isolated rat diaphragm can decarboxylate leucine (19), we decided to test the possibility that oxidation might be a major metabolic pathway for this amino acid in rat skeletal muscle. Upon completion of these studies, we learned that Manchester (27) had previously also found appreciable oxidation of leucine in rat diaphragm. This paper concerns factors that influence leucine metabolism in rat muscles; the subsequent one (13) studies the metabolism of the other amino acids by diaphragm from both normal and starved animals.
METHODS AND MATERIALS
Leucine-l-14C (28 mc/mmole) was purchased from New England Nuclear Corp. (Boston, Mass.) and leucine-U-W (3 10 mc/mmole) from Schwartz/Mann (Orangeburg, N.Y.). Crystallized bovine albumin (Pentex) was purchased from Miles Laboratories (Kankakee, Ill.). These experiments employed 60-to 90-g rats obtained from Charles River Breeding Laboratories and were fed ad libidum on Ralston Purina laboratory chow. The animals were killed by cervical dislocation, and the diaphragms were removed.
Each hemidiaphragm was dissected away from the associated ribs and cut into two pieces.
The soleus and the extensor digitorum longus muscles were dissected with their tendons intact. The muscles were weighed and then placed in 25-ml Erlenmeyer flasks containing 5 ml of KrebsRinger bicarbonate buffer (44) , such that tissue uptake of leucine did not significantly alter the extracellular concentration. To study adipose tissue, the epididymal fat pad was excised and a sample of approximately 30-50 mg was incubated in similar fashion to the diaphragm.
To prepare 0.5-mm slices of liver, kidney, and brain, these organs were rapidly excised and sectioned using a Stadie-Riggs tissue slicer. The kidney was cut lengthwise along the convex border so that slices included both medulla and cortex. Two or three slices totalling 25-75 mg of wet tissue were incubated with leucine-1 -14C (0.25 mc/mmole) at a concentration of 0.1 mM All incubations were carried out at 37 C in a rotary shaker (120 rpm).
Initial experiments showed that all the CO2 produced by the muscle could be recovered from the incubation medium. Thus, for measurement of labeled CO2, the muscle was removed from the flask, and the flask was immediately restoppered.
Sulfuric acid was added to drive off the dissolved CO 2, which was collected in 0.5 ml of Soluene (Packard Instrument Co., Downers Grove, Ill.) contained in a well above the incubation medium (3). To analyze 14C in tissue water and protein, the muscle was homogenized in 1.0 ml of cold 0.01 M potassium phosphate (PHI 7.4) with a Dual1 glass homogenizer (Kontes Glass Co., Vineland, N. J.). The homogenate was transferred to a centrifuge tube, and the homogenizer was rinsed with an additional 1 .O ml of the bu@er. Cold 50 % trichloroacetic acid (TCA) (0.5 ml) was added to precipitate proteins and the homogenate was centrifuged.
For measurement of TCA-soluble radioactivity, an aliquot of the supernatant was counted by liquid scintillation counting using the solution of Patterson and Greene (36). For measurement of 14C in protein, the precipitate was washed twice with 5 % TCA and once with 1: 1 ethanolether solution (11). The final precipitates were dissolved in 0.5 ml of Soluene and counted as described previously medium. The total amino acid uptake represents the sum of the 14C recovered in CO2, protein, and the TCA-soluble pool.
RESULTS
As shown in Fig. 1 , rat diaphragm has a marked ability to degrade leucine-l-14C to 14C02. In the absence of other carbon sources in the medium, production of i4C02 occurred at approximately 85 % the rate of incorporation of leucinelJ4C into protein. Both the 14C0 2 production and incorporation into protein were linear for 2.5 hr. By contrast, accumulation of leucine-1-14C into the TCA-soluble pool was maximal by 20 min and did not change during further incubation.
During this period, no decrease in the radioactivity in the medium could be measured. All subsequent experiments were carried out after 90 min of incubation, at which time catabolism to CO2 accounted for 38 %, and protein synthesis for 48 % of the labeled amino acid taken up by the diaphragm.
To determine whether the leucine molecule was completely oxidized by the diaphragm, the oxidations of leucine-1J4C and leucine-U-14C were compared. If the 14C0 2 production represented only a-decarboxylation of leucine-1 J4C (Fig. 1) , then muscles incubated with leucine-U-14C should liberate 14C0 2 at one-sixth the rate observed with leucine-l-14C. However, 14C0 2 production from leucine-U-14C occurred at about two-thirds the rate from leucine-1-14C (Table 1). Incorporation into protein and total amino acid uptake into the tissue were identical with either substrate. The lower amount of 14C02 from leucine-U-14C was accounted for by a greater amount of radioactivity in the TCA-soluble fraction. Negligible radioactivity (< 1 % of total uptake) was recovered in lipid extracted by the method of Folch, Lees, and Stanely (8).
The data in Table  1 are thus consistent with complete oxidation of the leucine molecule. Complete oxidation would not be expected to yield equal amounts of 14C0 2 from both substrates (at equal specific activities), since the complete degradation of leucine-u-14C produces many additional radioactive intermediates (e.g., acetateJ4C or acetoacetate-14C) that must be diluted in the cell by a large amount of nonradioactive material. Therefore, the average specific activity of the uniformly labeled material should be less than compounds labeled from leucine-1 -14C. This should result in decreased release of 14C02 from leucine-U-14C.
The metabolism of leucine-1-14C by diaphragm depended on the concentration of leucine in the medium (Fig. 2) . The radioactivity recovered in the TCA-soluble pool was linearly related to the external concentration. Similarly, the total uptake of leucine by the muscle and its oxidation to CO 2 both increased with increasing external concentration, and neither reached a maximum rate even at 5 mM. In sharp contrast to accumulation of TCA-soluble material, total uptake, and CO2 production, incorporation of leucine into protein was maximal at low levels of leucine with a half maximum rate at 0.13 mM. Thus, the amount of leucine degradation relative to its incorporation into protein increased IO-fold as the external concentration was raised from 0.1 to 5.0 mhf.
EJects of additional substrates on leucine oxidation. were present at higher concentrations than is normally found in rat plasma (22) .
Incubation of the diaphragm in the presence of all other amino acids at the concentrations normally found in rat plasma (26) depressed 14C02 production by 30-40 % but did not affect the incorporation of labeled leucine into protein ( Table 2 ). The addition of glucose (10 mM) in the presence of these amino acids depressed 14C02 production even further, and the percent inhibition caused by glucose in the presence of the amino acids was similar to that caused by glucose alone (Table  2) . Thus, the inhibitory actions of glucose and the amino acids on leucine oxidation were additive and independent of each other. Neither agent by itself nor both together affected the rate of incorporation into protein.
Experiments were undertaken to characterize this effect of the amino acids and to determine whether all of them were responsible for this inhibition. Table  3 shows that plasma levels of glutamic acid, glutamine, aspartic acid, asparagine, tyrosine, tryptophan, arginine, lysine, and histidine had no effect on 14C02 production when present as a group or in smaller combinations.
On the other hand, plasma concentrations of both isoleucine and valine, glycine and proline, a mixture of ornithine, citrulline, and cu-aminobutyric acid, or a mixture of cysteine, serine, and threonine all inhibited release of CO 2 from leucine-1-14C by 20-24 %. Alanine, by itself, was found repeatedly to inhibit leucine oxidation, and this effect increased with increasing alanine concentrations (Table  3) . However, the meaning of these various observations is unclear, since the degree of inhibition caused by all the amino acids together was consistently less than the sum of the inhibitory effects observed when the various amino acids were tested individually (Table 3 ). In addition,
in certain experiments, combinations of amino acids did not produce significant inhibition, even though the same compounds tested individually or in smaller groups appeared inhibitory.
Thus, on the basis of these experiments it cannot be concluded whether any amino acids are specifically responsible for the effects of the whole group.
Effects of metabolic inhibitors. Further experiments examined the effects of inhibition of protein synthesis and energy metabolism on the rate of leucine oxidation (Table 4) . At a concentration which reduced incorporation into protein by 93 %, cycloheximide caused an 80 % increase in the rate of CO2 production.
Thus, in the presence of the inhibitor, the amino acids, which are normally incorporated into muscle proteins, instead appear to be catabolized.
At the same time, treatment with cycloheximide increased the amount of label in the TCA-soluble pool, even though the total amount of leucine-lJ4C taken up by the muscle appeared to decrease. Leucine oxidation appears to require an intact cytochrome system, since potassium cyanide markedly inhibited this process as well as protein synthesis. Although cyanide appeared to decrease the total uptake of leucine by the muscle by 55 %, this agent, like cycoheximide, actually increased the accumulation of label in the TCA-soluble pool. Similar results were obtained with potassium iodoacetate, an inhibitor of glycolysis. This agent greatly reduced CO2 production from leucine, incorporation into protein, and total leucine uptake by the muscle. Nevertheless, in the presence of iodoacetate, the content of leucine in the TCA-soluble pool increased significantly.
The active transport of many amino acids into muscle requires the presence of sodium ions in the extracellular medium and can be inhibited by ouabain (41). When the external sodium was replaced by choline or when ouabain was added to the medium, 14C0 2 production from leucine-1-14C was not significantly affected (Table  5) . Similarly, ouabain did not affect accumulation of label in the TCAsoluble pool and removal of sodium only slightly decreased the pool radioactivity.
This process thus does not appear to depend upon a Na+-dependent transport system. On the other hand, the incorporation into protein and the total uptake of amino acids were markedly reduced by both treatments. These observations suggest that the oxidative pathway unlike protein synthesis is independent of the Na+-linked amino acid transport system. Leucine oxidation in other tissues. 7+e red soleus and pale extensor digitorum longus muscles also have marked capacity to oxidize leucine (Fig. 3) . There was no significant difference in the rates of CO2 production by these muscles, although incorporation of this amino acid into protein was significantly larger in the soleus. The rates of CO2 production, incorporation into protein, and total uptake measured in these muscles are lower than found for the diaphragm (Fig. 1) . Comparison between behavior of these muscles and the diaphragm is complicated by differences in the thickness of the tissues and consequently in the diffusion rates of substrates.
Additional experiments were undertaken to compare muscle with other tissues in their pattern of leucine metabolism. The rates of 14C02 production as well as of incorporation varied widely in the different tissues examined (Table  6 ). Liver slices degraded leucine at a similar or slightly lower rate than diaphragm.
However, 14C02 production by kidney slices was fivefold greater, by brain slices fourfold greater, and by epidydimal fat pad threefold greater than that by diaphragm.
These rates of leucine catabolism did not correlate in any simple manner with the relative rates of leucine incorporation into protein in the different tissues. Brain and adipose tissue both incorporated appreciably less 14C than the muscle, whereas liver was twice and kidney 3 times as active as the diaphragm in this process. Such absolute measurement may reflect differences in the rate of entry or specific activity of the labeled precursor.
However, the ratios of 14C recovered in CO2 to that in protein in the various tissues further demonstrate that the oxidation of leucine was of relatively minor importance in liver as compared to muscle, whereas the degradative pathway was of greater significance in kidney, brain, and adipose tissue. In fact, in brain and adipose tissue leucine catabolism occurred approximately 7-l 0 times more rapidly than inincorporation of labeled leucine into protein by 74 and 44 %, respectively (Table 5) . At the same time these agents decreased leucine oxidation and accumulation into the intracellular pool slightly or not at all. These findings may indicate some unknown, inhibitory effect of ouabain or sodium removal on the protein synthetic machinery.
Alternatively, they may indicate functional specialization of the two pathways for leucine uptake into muscle: a Na-depend .ent, ouabain-sensitive transport system which supplies amino acids for protein synthesis and a sodium-independent one primarily supplying amino acids for the degradative systems and the TCA-soluble pool. The inability to saturate the transport system and the oxidative pathway with high external concentrations of leucine (Fig. 2) also suggests that the leucine transport system supplying most of the TCA-soluble pool may be functionally related to the catabolic pathway rather than protein synthesis. Tests of this possibility are in progress. Others have suggested that protein synthesis in muscle is dependent on the continued transport of amino acids across the cell membrane rather than on the supply of such compounds from the intracellular (TCA-soluble) I pool (16, 17). Thus, it is possible that the precursor pools for oxidation and for protein synthesis are distinct. However, our findings that cycloheximide stimulated 14C0 2 production ( In both the soleus and the extensor digitorum longus of the rat, leucine oxidation occurs at similar rates to incorporation into protein (Fig. 3 ) In addition, there seems to be no significant difference in the oxidation of leucine by the soleus, which contains predominantly dark fibers, and by the extensor digitorum longus, which contains primarily pale fibers (15, 42) . These studies crease in its phenomena rate of uptake by the muscle. Studies of these are now in progress. The data in Fig. 2 also confirm previous findings in vivo (7, 10 ) that amino acid incorporation by red muscles exceeds that of pale muscles. In fact, the relative rates of incorporation measured here for the isolated diaphragm, soleus, and extensor digitorum longus are in accord with the relative rates found in intact animals (10).
The present measurements of leucine metabolism by diaphragm are in general accord with those of Manchester (2 7). However, calculations from Manchester's data indicate that the amount and proportion of leucine entering protein in his study were half as great as those in Fig. 2 , whereas total leucine uptake and CO2 production exceeded those found here by 20-50 %. These apparent differences may simply reflect the small number of animals used in the earlier experiments but may also be related to differences in the weight, strain, or diet in the two studies. Recently, Pain and Manchester (34) have also reported catabolism of leucine by the extensor digitorum longus, although these workers observed only 22 % of the 14C02 production shown in Fig. 3 . The values for amino acid incorporation into protein in the two studies were equal. The reason for this discrepancy is presently unclear.
Since CO2 production (Tables 2 and 3 ) tias observed in the presence of physiological concentrations of glucose, other metabolic substrates, and plasma concentrations of amino acids, it appears very probable that muscle and other tissues burn leucine at an appreciable rate in vivo. The actual rates of leucine catabolism in the organism are difficult to estimate.
In one respect, the present measurements must significantly underestimate the absolute rate of leucine catabolism, since they have assumed that the specific activity of 14C0 2 derived from leucine-lJ4C equaled that of the incubation medium. However, the intracellular specific activity of leucine and its labeled metabolites must be less than that in the medium, because of the unlabeled material present in the cell initially or produced during the experiment by protein breakdown.
In fact, measurements of the intracellular leucine content suggest that the present measurements may be too low by approximately severalfold (unpublished data). On the other hand, since the present data were generally obtained for cells incubated in the presence of leucine alone or leucine plus glucose, they have ignored inhibitory actions of the serum amino acids (Tables 2 and 3 ) and thus may overestimate the rates of oxidation by 30-40 %. Preliminary studies suggest that serum concentrations of amino acids inhibit leucine oxidation not only in the diaphragm (Tables 2 and 3 ), but also in other tissues as well, although the magnitude of this effect varies in different tissues (unpublished data). Although the nature of the inhibition caused by the amino acids is puzzling (Table 3) , this inhibition may be of appreciable physiological significance, and variations in blood levels of the amino acids or glucose (as seen, for example, in fasting or diabetes (2, 39, 43) ) may in this way influence rates of oxidation of leucine in different tissues. The data in Table 6 confirm earlier reports that leucine can be oxidized by tissue slices from brain (3), skeletal muscle ( 19, 27) , adipose tissue ( 14), kidney (6) , and liver ous tissues cited in this table assume similar intracellular specific activities of leucine, and the validity of this assumption is yet to be tested. It is interesting, nevertheless, that the conclusions of appreciable leucine oxidation by kidney and muscle and less activity by rat liver are in accord with the relative concentration of leucine transaminase in these tissues (46) . By contrast, two groups have claimed that the branched-chain ar-ketoacid dehydrogenase is virtually absent from all tissues except the liver and the kidney (5, 45). In our laboratory extracts of rat skeletal muscle have been found highly active in decarboxylatitin of leucine (unpublished data). The previous failure to find this activity may result from the failure to assay the muscle extract at the optimal pH for the muscle enzyme (unpublished data). Although the actual rates of leucine oxidation by tissues in the intact organism are yet to be determined, the findings in Table 6 suggest that skeletal muscle is the major site for leucine oxidation in the body. Even though the capacity of the diaphragm to catabolize leucine appears similar to that of the liver, and several times smaller than that of the kidney or brain, skeletal muscle constitutes 43 % of the body mass, whereas the liver represents only 3 %, kidney, 1 %, and the brain, 1 % (23). Therefore, the skeletal muscle of the body would be expected on the basis of Fig. 1 to degrade leucine at approximately 3 times the rate of the liver, kidney, and brain together.
Adipose tissue, which also catabolizes leutine quite rapidly, varies appreciably in amount in different individuals;
at most fat represents 10 % of the body weight of normal growing rats, and even in such obese animals, skeletal muscle would be expected to account for about 50 % of leucine catabolism of the body. It is of interest that the rate of leucine oxidation by diaphragm observed here (Fig. 1 ) is sufficient to account completely for the total leucine catabolism found in adult rats by MacFarlane and Von Holt (25), who injected leucineJ4C in rats and collected expired CO 2.
These experiments also raise the possibility that amino acids are an energy source for skeletal muscle and the other tissues. Complete oxidation of leucine, which occurs in muscle (Table  1 ) , yields more ATP molecules on a molar basis than complete oxidation of glucose (21) . Under the present experimental conditions (i.e., with glucose or with leucine as the only exogenous carbon source), the diaphragm catabolized leucine-lJ4C (0.1 mM) to 14C0 2 at about 9 % of the rate that it degraded glucose (10 mM) to 14C0 2. Nevertheless, the total contribution of amino acids to muscle energy metabolism in the body could be significant, since in addition to leucine several other amino acids found in plasma are readily degraded by the diaphragm (13) .
Furthermore, a .s shown in the subsequent paper (13 I), the inherent ability of muscle certain physiological states, th Since .e rate the absolute relative to pro in kidney slices, tine catabolism to oxidize leucine increases in such as food deprivation. rate of brain tein syn leucine ca tabolism as well as thesis were significantly higher slices, and epidydimal fat pad, leurepresent an even more important energy source for these tissues. However, in adipose tissue, unlike skeletal muscle (Table  l) , a large fraction of the (29, 30). However, the relative oxidative rates in the variproducts of leucine decarboxylation is subsequently incor-porated into fatty acids and triglycerides (14). It is presently unclear whether kidney and brain also incorporate the leucine chain into fats. Hopefully, further studies will clarify the importance of this catabolic pathway for energy metabolism and its relevance to the control of amino acid pools and protein synthesis.
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